Correlation Between Inhibikase Therapeutics and Nutriband
Can any of the company-specific risk be diversified away by investing in both Inhibikase Therapeutics and Nutriband at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibikase Therapeutics and Nutriband into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibikase Therapeutics and Nutriband, you can compare the effects of market volatilities on Inhibikase Therapeutics and Nutriband and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibikase Therapeutics with a short position of Nutriband. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibikase Therapeutics and Nutriband.
Diversification Opportunities for Inhibikase Therapeutics and Nutriband
-0.62 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Inhibikase and Nutriband is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding Inhibikase Therapeutics and Nutriband in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nutriband and Inhibikase Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibikase Therapeutics are associated (or correlated) with Nutriband. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nutriband has no effect on the direction of Inhibikase Therapeutics i.e., Inhibikase Therapeutics and Nutriband go up and down completely randomly.
Pair Corralation between Inhibikase Therapeutics and Nutriband
Considering the 90-day investment horizon Inhibikase Therapeutics is expected to under-perform the Nutriband. But the stock apears to be less risky and, when comparing its historical volatility, Inhibikase Therapeutics is 1.44 times less risky than Nutriband. The stock trades about -0.18 of its potential returns per unit of risk. The Nutriband is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 427.00 in Nutriband on October 20, 2024 and sell it today you would lose (16.00) from holding Nutriband or give up 3.75% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inhibikase Therapeutics vs. Nutriband
Performance |
| Timeline |
| Inhibikase Therapeutics |
| Nutriband |
Inhibikase Therapeutics and Nutriband Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inhibikase Therapeutics and Nutriband
The main advantage of trading using opposite Inhibikase Therapeutics and Nutriband positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibikase Therapeutics position performs unexpectedly, Nutriband can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nutriband will offset losses from the drop in Nutriband's long position.| Inhibikase Therapeutics vs. DiaMedica Therapeutics | Inhibikase Therapeutics vs. Milestone Pharmaceuticals | Inhibikase Therapeutics vs. Seres Therapeutics | Inhibikase Therapeutics vs. Oncolytics Biotech |
| Nutriband vs. Quoin Pharmaceuticals Ltd | Nutriband vs. Longeveron LLC | Nutriband vs. RenovoRx | Nutriband vs. Virax Biolabs Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |